SPC287

Eftrenónacog alfa eða lífræn hliðstæðuafurð í samræmi við grein 10(4) í ákvörðun 2001/83/EC

  • Status:
    Afskrifuð
  • Application date:
    30.1.2020
  • Application published:
    15.2.2020
  • Max expiry date:
    12.5.2031
  • Medicine name:
    Alprolix
  • Medicine for children:
    No

Timeline

Today
30.1.2020Application
15.2.2020Publication
12.5.2031Expires

Marketing license

    • Foreign authorization number:
      EU/1/16/1098
    • Date:
      12.5.2016

    Owner

    Agent

    • Name:
      Árnason Faktor ehf.
    • Address:
      Guðríðarstíg 2-4, 113 Reykjavík

    Patent

    Upload documents